Karen Katen is retired Vice Chairman of Pfizer, the world's largest pharmaceutical company; and she is chairman of the Pfizer Foundation, the company's global philanthropic arm devoted to supporting healthcare access, education and community outreach initiatives.
Most recently, Katen served as President of Pfizer Human Health - the company's principal operating group, responsible for discovery, development, manufacture, distribution and commercialization of prescription medicines, and for providing a broad array of innovative human-health services. Katen joined Pfizer in 1974.
Karen Katen was named among the top ten in Fortune Magazine's ranking of "50 Most Powerful Women in Business" again in 2005, a list that included her for eight consecutive years.
Karen Katen received her BA and MBA from the University of Chicago, where she now serves as a University Trustee and a council member of its Graduate School of Business.
When I started my career at Pfizer three decades ago, a relatively small company at the time, we were lost somewhere in the middle of the pharmaceutical pack, but I quickly developed faith in our mission which was then and remains to discover, to develop, and to bring to the market new medicines tha...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
